The Variation in the Traits Ameliorated by Inhibitors of JAK1/2, TGF-β, P-Selectin, and CXCR1/CXCR2 in the Gata1low Model Suggests That Myelofibrosis Should Be Treated by These Drugs in Combination

Francesca Gobbo(University of Bologna), Anna Ritá Migliaccio(Altius Institute for Biomedical Sciences)

International Journal of Molecular Sciences

July 13, 2024

10.3390/ijms25147703

Cited by 4

Related Papers

Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1 mouse model

|Experimental Hematology|2022|8